Avokadio is a company that has developed a pocket-sized device to measure an individual's fat metabolism through breath analysis. The technology is based on analyzing breath gasses to determine nutritional deficiencies and provide personalized guidance for healthy eating habits. The device offers a non-invasive and affordable alternative to expensive blood or urine tests for monitoring one's nutritional status.
Avokadio's device enables users to track their nutritional deficiencies and receive instant personalized data to promote wellness through healthy eating. The company's clinical trial results demonstrated that individuals using the device and following the provided diet program achieved significant results within just one week.
The company claims that through its offering, users can reduce their risk of developing type 2 diabetes.
As of July 2024, the company was offering one subscription plan at USD 199 per month for access to its platform and meal plans, a breathalyzer, and the ability to consult with experts.
Key customers and partnerships
The company noted that as of July 2024, more than 1,000 users were utilizing its platform.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.